173 related articles for article (PubMed ID: 34044044)
1. Mining the Mycobacterium tuberculosis proteome for identification of potential T-cell epitope based vaccine candidates.
Madan R; Pandit K; Bhati L; Kumar H; Kumari N; Singh S
Microb Pathog; 2021 Aug; 157():104996. PubMed ID: 34044044
[TBL] [Abstract][Full Text] [Related]
2. Design of a peptide-based vaccine from late stage specific immunogenic cross-reactive antigens of PE/PPE proteins of Mycobacterium tuberculosis.
Medha ; Priyanka ; Sharma S; Sharma M
Eur J Pharm Sci; 2022 Jan; 168():106051. PubMed ID: 34744006
[TBL] [Abstract][Full Text] [Related]
3. Identification and evaluation of immunogenic MHC-I and MHC-II binding peptides from Mycobacterium tuberculosis.
Jagadeb M; Pattanaik KP; Rath SN; Sonawane A
Comput Biol Med; 2021 Mar; 130():104203. PubMed ID: 33450502
[TBL] [Abstract][Full Text] [Related]
4. Predicting promiscuous antigenic T cell epitopes of Mycobacterium tuberculosis mymA operon proteins binding to MHC Class I and Class II molecules.
Saraav I; Pandey K; Sharma M; Singh S; Dutta P; Bhardwaj A; Sharma S
Infect Genet Evol; 2016 Oct; 44():182-189. PubMed ID: 27389362
[TBL] [Abstract][Full Text] [Related]
5. Designing of a Chimeric Vaccine Using EIS (Rv2416c) Protein Against Mycobacterium tuberculosis H37Rv: an Immunoinformatics Approach.
Logesh R; Lavanya V; Jamal S; Ahmed N
Appl Biochem Biotechnol; 2022 Jan; 194(1):187-214. PubMed ID: 34817805
[TBL] [Abstract][Full Text] [Related]
6. Immunoinformatics analysis of antigenic epitopes and designing of a multi-epitope peptide vaccine from putative nitro-reductases of Mycobacterium tuberculosis DosR.
Shiraz M; Lata S; Kumar P; Shankar UN; Akif M
Infect Genet Evol; 2021 Oct; 94():105017. PubMed ID: 34332157
[TBL] [Abstract][Full Text] [Related]
7. Computational approaches in epitope design using DNA binding proteins as vaccine candidate in Mycobacterium tuberculosis.
Sunita ; Singhvi N; Singh Y; Shukla P
Infect Genet Evol; 2020 Sep; 83():104357. PubMed ID: 32438080
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of late stage specific peptide antigens of Mycobacterium tuberculosis.
Singh M; Bhatt P; Sharma M; Varma-Basil M; Chaudhry A; Sharma S
Infect Genet Evol; 2019 Oct; 74():103930. PubMed ID: 31228643
[TBL] [Abstract][Full Text] [Related]
9. Immunoinformatics based design and prediction of proteome-wide killer cell epitopes of
Kashif M; Hira SK; Manna PP
J Biomol Struct Dyn; 2022; 40(21):10578-10591. PubMed ID: 34219625
[TBL] [Abstract][Full Text] [Related]
10. A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice.
Geluk A; van den Eeden SJ; van Meijgaarden KE; Dijkman K; Franken KL; Ottenhoff TH
Vaccine; 2012 Dec; 30(52):7513-21. PubMed ID: 23103299
[TBL] [Abstract][Full Text] [Related]
11. Computational Identification and Characterization of a Promiscuous T-Cell Epitope on the Extracellular Protein 85B of
Hossain MS; Azad AK; Chowdhury PA; Wakayama M
Biomed Res Int; 2017; 2017():4826030. PubMed ID: 28401156
[TBL] [Abstract][Full Text] [Related]
12. Epitope-driven TB vaccine development: a streamlined approach using immuno-informatics, ELISpot assays, and HLA transgenic mice.
McMurry JA; Kimball S; Lee JH; Rivera D; Martin W; Weiner DB; Kutzler M; Sherman DR; Kornfeld H; De Groot AS
Curr Mol Med; 2007 Jun; 7(4):351-68. PubMed ID: 17584075
[TBL] [Abstract][Full Text] [Related]
13. Identification of epitope-based peptide vaccine candidates against enterotoxigenic Escherichia coli: a comparative genomics and immunoinformatics approach.
Mehla K; Ramana J
Mol Biosyst; 2016 Mar; 12(3):890-901. PubMed ID: 26766131
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the DosR regulon genes to select cytotoxic T lymphocyte epitope specific vaccine candidates using a reverse vaccinology approach.
Pandey K; Sharma M; Saarav I; Singh S; Dutta P; Bhardwaj A; Sharma S
Int J Mycobacteriol; 2016 Mar; 5(1):34-43. PubMed ID: 26927988
[TBL] [Abstract][Full Text] [Related]
15. Integrated computational prediction and experimental validation identifies promiscuous T cell epitopes in the proteome of
Farrell D; Jones G; Pirson C; Malone K; Rue-Albrecht K; Chubb AJ; Vordermeier M; Gordon SV
Microb Genom; 2016 Aug; 2(8):e000071. PubMed ID: 28348866
[TBL] [Abstract][Full Text] [Related]
16. In silico analysis of potential human T Cell antigens from Mycobacterium tuberculosis for the development of subunit vaccines against tuberculosis.
Devasundaram S; Deenadayalan A; Raja A
Immunol Invest; 2014; 43(2):137-59. PubMed ID: 24467664
[TBL] [Abstract][Full Text] [Related]
17. Epitope promiscuity and population coverage of Mycobacterium tuberculosis protein antigens in current subunit vaccines under development.
Ong E; He Y; Yang Z
Infect Genet Evol; 2020 Jun; 80():104186. PubMed ID: 31923726
[TBL] [Abstract][Full Text] [Related]
18. Conservation in gene encoding Mycobacterium tuberculosis antigen Rv2660 and a high predicted population coverage of H56 multistage vaccine in South Africa.
Perez-Martinez AP; Ong E; Zhang L; Marrs CF; He Y; Yang Z
Infect Genet Evol; 2017 Nov; 55():244-250. PubMed ID: 28941991
[TBL] [Abstract][Full Text] [Related]
19. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
Mortier MC; Jongert E; Mettens P; Ruelle JL
BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
[TBL] [Abstract][Full Text] [Related]
20. In silico prediction of CD8
Kashif M; Waseem M; Subbarao N
J Mol Graph Model; 2024 Jun; 129():108759. PubMed ID: 38492406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
